- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr William Cliby Discusses Improving Surgical Outcomes in Ovarian Cancer
We’ve done a lot of work on quality improvement, such as enhancing recovery, reducing intestinal injury during and after surgery, and reducing infections after surgery, explained William Cliby, MD, consultant, division of gynecologic surgery, department of obstetrics & gynecology, Mayo Clinic.
We’ve done a lot of work on quality improvement, such as enhancing recovery, reducing intestinal injury during and after surgery, and reducing infections after surgery, explained William Cliby, MD, consultant, division of gynecologic surgery, department of obstetrics & gynecology, Mayo Clinic.
Transcript
What surgical quality improvement measure have you focused on to improve surgical outcomes for patients with ovarian cancer?
For us, it’s taken 2 shapes. One is to reduce the amount of residual disease in the patient at the end of their first surgery. We think that puts them in the best position to respond to chemotherapy. So, we’ve spent a lot of effort at our own place and the Society of Gynecologic Oncology has, as well, to try to improve the surgical quality. Leaving less residual disease, using upper abdominal resection techniques to get the best quality surgery.
More specifically, to the actual surgical event, is steps to reduce the complications after surgery. We’ve done a lot of work on quality improvement, whether it’s enhanced recovery, so faster recovery for patients, reducing intestinal injury during and after surgery, reducing infections after surgery as well. All of those things have allowed us to reduce our complication rate and so reduce the amount of poor outcomes relative to good outcomes.
The Push for Fair Pricing and Reform in Pharmacy Benefit Management
April 3rd 2025Amid growing legislative pressures and industry debates, pharmacy benefit managers (PBMs) are exploring new strategies to enhance transparency, reduce patient costs, and navigate the evolving healthcare landscape.
Read More
Exploring Racial, Ethnic Disparities in Cancer Care Prior Authorization Decisions
October 24th 2024On this episode of Managed Care Cast, we're talking with the author of a study published in the October 2024 issue of The American Journal of Managed Care® that explored prior authorization decisions in cancer care by race and ethnicity for commercially insured patients.
Listen
Using AI-Driven Strategies to Optimize Specialty Drug Costs, Manage Polypharmacy
April 2nd 2025As health care costs continue to rise, artificial intelligence (AI)-driven solutions are emerging as a powerful tool for managing specialty drug spending and polypharmacy risks, as showcased in recent research presented at the Academy of Managed Care Pharmacy 2025 conference.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
How Recent Federal Policy Changes Are Shaping Managed Care Pharmacy
April 2nd 2025Federal legislative and regulatory changes are reshaping pharmacy practice, with key challenges in government funding, pharmacy benefit manager reform, and health care policy shifts—topics explored by experts at the Academy of Managed Care Pharmacy's annual meeting.
Read More
